Federal regulationCanada Gazette, Part IComment Period Closed

GI-2025-26-reg2: Order Amending Schedule IX to the Controlled Drugs and Substances Act

Sponsoring body: Health, Dept. ofIntroduced June 28, 2025Last checked August 25, 2026

Read the official text on gazette.gc.caOfficial version — Canada Gazette, Part I

What this regulation does

This proposed order updates Schedule IX of the Controlled Drugs and Substances Act to expand the definition of regulated tablet press and capsule-filling equipment, including components like dies, moulds, and punches, whether assembled, partially assembled, or disassembled.

Plain-language summary by Legisail.

Business impact

Compliance

Businesses that manufacture, sell, import, or possess tablet presses, capsule-filling machines, and related components (dies, moulds, punches) will be subject to increased regulatory oversight under the Precursor Control Regulations. This affects pharmaceutical manufacturers, supplement companies, and equipment suppliers — even if the equipment is unassembled or sold in parts. The full cost and compliance details are contained in the associated RIAS for the Regulations Amending the Precursor Control Regulations (Increased Regulatory Oversight), which was not provided here. Businesses dealing in this type of equipment should review that companion RIAS to understand their specific licensing, record-keeping, or reporting obligations.

Does this apply to you?

Your own business or clients you watch for — tell Legisail what matters and it checks every bill and regulation against it.

Check for free

Where this regulation is

Proposed

Comment period closed